Advertisement
Advertisement

PMN

PMN logo

ProMIS Neurosciences Inc.

0.95
USD
+0.0166
+1.78%
Jan 23, 12:51 UTC -5
Closed
...

ProMIS Neurosciences Inc. Profile

About

ProMIS Neurosciences Inc. is a development stage biotechnology company. It focused on discovering and developing medicine therapeutics to treat neurodegenerative diseases in particular Alzheimer's disease and amyotrophic lateral sclerosis. The company's product portfolio includes PMN310, PMN350, PMN330, PMN110, PMN120 and PMN130 which are in its pre-clinical stage. ProMIS Neurosciences Inc.is headquartered in Toronto, Canada.

Info & Links

CEO

Neil Warma

Headquarters

SUITE 200, 1920 YONGE STREET
TORONTO, A6 M4S 3E2, CANADA

Industry

Biotechnology

Sector

Health Technology

Website

www.promisneurosciences.com

Auditor

Baker Tilly US, LLP

Share holders

--

Employees

7

ProMIS Neurosciences Inc. Statistics

Valuation Measures

Market Capitalization2

31.06M

Enterprise Value

9.52M

Enterprise Value/EBITDA(ttm)

-0.65

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

4.06

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-636.20%

Return on Invested Capital(ttm)

-4567.47%

Return on Assets(ttm)

-130.32%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-14.68M

Net Income Available to Common(ttm)

-563.40K

Diluted EPS(ttm)

-0.10

Share Statistics

Beta (5Y Monthly)

0.54

52-Week Change

-19.49%

S&P 500 52-Week Change

25.43%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

32.69M

Dividend Yield

0.00%

Float4

31.25M

% Held by Insiders

4.40%

% Held by Institutions

50.13%

Balance Sheet

Total Cash(mrq)

21.57M

Total Cash Per Share(mrq)

0.66

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

9.30%

Quick Ratio(mrq)

9.30%

Book Value Per Share(mrq)

0.22

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.61

Free Cash Flow(ytd)

-18.47M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement